The WVU Cancer Institute’s Cancer Prevention and Control has expanded its Bridge Program that focuses on lung cancer survivorship to United Hospital Center (UHC) in Bridgeport. The goal of the Bridge Program is to improve the coordination of care and decrease the consequences of treatment for patients diagnosed with stage I, II, or III lung cancer after they complete treatment.
“It has been an exciting opportunity to be part of this project from the early stages with the WVU Cancer Institute, as a gap in care has been identified for the lung cancer survivors of West Virginia,” Linda Carte, RN, MSN, AOCN, vice president of oncology and post-acute care at United Hospital Center, said. “While lung cancer survivors are the first to have the opportunity to participate in this Bridge Program, it is a model that can certainly be extended to all those surviving cancer to improve quality of life after diagnosis and treatment. We are looking forward to this ongoing collaboration to improve cancer care for the many communities we serve.”
The Bridge Program brings together healthcare professionals from multiple disciplines to create a comprehensive care plan tailored to the specific needs of each patient. During a half-day clinic, each patient has the opportunity to meet individually with a nurse practitioner, licensed social worker, dietitian, psychiatrist, physical therapist, and occupational therapist.
The program is funded by the Bristol-Myers Squibb Foundation’s "Bridging Cancer Care" initiative.
WVU Cancer Institute's Cancer Prevention and Control, in collaboration with the West Virginia Cancer Registry, has released the 2018 Cancer Burden Report. The report provides updated statewide, age-adjusted incidence rates and counts for cancer diagnosed among West Virginia residents from 2011 to 2015.
West Virginia University's Cancer Institute is well-known for its treatment and innovation. Leading the institute is Dr. Richard Goldberg, who has not only established himself as a transformative leader but also a potent researcher and educator.
Brian Boone, M.D., surgical oncologist in the WVU Medicine Department of Surgery and WVU Cancer Institute, performed the state’s first hyperthermic intraperitoneal chemotherapy (HIPEC) infusion. This treatment delivers heated, sterilized chemotherapy to the abdomen as a treatment for cancer that has spread to the lining of the abdominal cavity, or peritoneum.